China Resources Pharma Discloses Nine-Month Unaudited Results of Dong-E-E-JiaoTip Ranks·Oct 23, 2026 at 10:40 AM03320-1.79%000423+2.15%
Dong-E-E-Jiao, China Resources Pharma subsidiary, posts H1 net profit RMB 860.38 million, up 5.66%PUBT·Aug 20, 2026 at 09:20 AM000423+2.15%
